Yesterday, Global Pharmatech Inc (OTCMKTS: GBLP) had come into sharp focus among investors and its stock emerged as one of the biggest gainers as it ended up with gains of as much as 32% amidst heavy interest.
Trading Data
On Wednesday, GBLP stock ended flat at $0.2000 with more than 17.89K shares, compared to its average volume of 0 shares. The stock moved within a range of $0.2000 – 0.2000 after opening trading at $0.1500.
Global Pharmatech, Inc. Completes the Transaction to Acquire Botaniex, Inc.
The company came into focus yesterday after it announced that it had concluded the transaction to acquire the entirety of the issued and outstanding stock of the Delaware corporationBotaniex Inc. Botaniex operates in Changsha in China and the definitive share purchase agreement had been executive back on December 18, 2022. In order to complete the transaction, Global Pharmatech had issued a total of 112,360,000 fresh restricted shares, which were exchanged for all the issued and outstanding shares of Botaniex.
On a fully diluted basis, shareholders of Botaniex would not own anu less than 28% of the total outstanding and issued shares in Global Pharmatech. Once the transaction was closed, Yong Sheng resigned from his positions of Secretary, President of the Treasury and Chief Executive Officer at Global Pharmatech. However, he would continue to serve in the capacity of a director at the company. The President of Botaniex, Melson Liao would take up those positions instead.
